Acta Scientific Clinical Case Reports

Case ReportVolume 2 Issue 6

A Good History Can Unlock Puzzle- A Case Report of Ibuprofen Induced Minimal Change Glomerulonephritis

Anusha Yanamadala* and Parikshit Thakur Hameer

Presbyterian Plains Regional Medical Center; Clovis, NM, USA

*Corresponding Author: Anusha Yanamadala, Presbyterian Plains Regional Medical Center; Clovis, NM, USA.

Received: April 15, 2021; Published: June 02, 2021

Citation: Anusha Yanamadala and Parikshit Thakur Hameer. “A Good History Can Unlock Puzzle- A Case Report of Ibuprofen Induced Minimal Change Glomerulonephritis". Acta Scientific Clinical Case Reports 2.7 (2021): 21-22.

Abstract

Minimal-change disease (MCD) is uncommon in adults contributing about 10% of nephrotic syndrome cases in adults. Underlying pathology is thought to be due to T-cell or B- cell dysfunction resulting in circulating factors like IL-13 affecting glomerular capillary wall permeability resulting in significant proteinuria. NSAIDs (Nonsteroidal anti-inflammatory drugs) are common cause for secondary MCD but often underdiagnosed with missing information from history. Untreated MCD were associated with a high risk for thromboembolism and mortality. We are presenting a case report of ibuprofen induced minimal change glomerulonephritis in a young patient who took ibuprofen on a regular basis with a history of fracture for pain management without subsequent monitoring and unaware of significant side effects of medication.

 

Keywords: Ibuprofen; Glomerulonephritis; Minimal-Change Disease (MCD)

Bibliography

  1. Lai KW., et al. “Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats”. Journal of the American Society of Nephrology 5 (2007): 1476-1485.
  2. Tune BM and Mendoza SA. “Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults”. Journal of the American Society of Nephrology 5 (1997): 824-832.

Copyright: © 2021 Anusha Yanamadala and Parikshit Thakur Hameer. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


Contact US